Strategic Planning Group LLC Acquires 785 Shares of Danaher Co. (NYSE:DHR)

Strategic Planning Group LLC grew its holdings in Danaher Co. (NYSE:DHR) by 5.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 14,276 shares of the conglomerate’s stock after acquiring an additional 785 shares during the period. Strategic Planning Group LLC’s holdings in Danaher were worth $3,277,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Coronation Fund Managers Ltd. raised its stake in shares of Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after buying an additional 1,470 shares during the period. Ascent Group LLC raised its stake in Danaher by 30.2% during the 2nd quarter. Ascent Group LLC now owns 2,205 shares of the conglomerate’s stock worth $551,000 after acquiring an additional 512 shares during the period. Quarry LP raised its stake in Danaher by 250.6% during the 2nd quarter. Quarry LP now owns 298 shares of the conglomerate’s stock worth $74,000 after acquiring an additional 213 shares during the period. B. Riley Wealth Advisors Inc. lifted its holdings in Danaher by 5.0% during the second quarter. B. Riley Wealth Advisors Inc. now owns 11,035 shares of the conglomerate’s stock valued at $2,760,000 after purchasing an additional 527 shares in the last quarter. Finally, Cetera Investment Advisers boosted its position in shares of Danaher by 6.5% in the second quarter. Cetera Investment Advisers now owns 130,209 shares of the conglomerate’s stock worth $32,533,000 after purchasing an additional 7,986 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

NYSE:DHR opened at $223.12 on Thursday. The firm has a market capitalization of $161.15 billion, a PE ratio of 42.58, a PEG ratio of 4.43 and a beta of 0.83. The stock’s fifty day moving average is $236.09 and its 200 day moving average is $253.66. Danaher Co. has a fifty-two week low of $223.00 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same period in the prior year, the company earned $2.09 EPS. On average, sell-side analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. Danaher’s dividend payout ratio is 20.61%.

Analysts Set New Price Targets

DHR has been the topic of a number of recent analyst reports. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Robert W. Baird lowered their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Raymond James lowered their target price on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Finally, UBS Group cut their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $284.14.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.